WZWenhua Zhan

Wenhua Zhan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wenhua Zhan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Bing Tang

    Center for Aortic Surgery, Beijing Anzhen Hospital of Capital Medical University, Beijing 101118, China

    1 shared publication
  • Dongjie Yang

    Department of Gastrointestinal and Pancreatic Surgery, The first Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China

    1 shared publication
  • Lian-Zhou Chen

    Laboratory of Department of Surgery, First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan Rd II, Guangzhou, Guangdong, 510080, People's Republic of China

    1 shared publication
  • Tuckyun Cheang

    Department of Gastrointestinal and Pancreatic Surgery, The first Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China

    1 shared publication
  • Weiling He

    Department of Gastrointestinal Surgery, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

    1 shared publication
  • Wen Li

    Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients

    by Weiling He, Bing Tang, Dongjie Yang, Yuhuang Li, Wu Song, Tuckyun Cheang, Xinlin Chen, Yin Li, Lianzhou Chen, Wenhua Zhan, et al.

    Although many studies have indicated that high-mobility group box 1 protein (HMGB1) is associated with oncogenesis and a worse prognosis, the prognostic value of HMGB1 in gastric cancer (GC) remains unclear. In the present work, we aimed to evaluate the role of HMGB1 in GC and examined whether aberrant expression of both HMGB1 and vascular endothelial growth factor C (VEGF-C) increased the malignant potential of GC. A total of 166 GC patients and 32 normal subjects were enrolled. HMGB1 and VEGF-C expression was detected by tissue microarrays (TMAs) and immunohistochemical staining. The correlation between HMGB1 and VEGF-C expression and their relationships with clinicopathological GC variables were examined. Univariate and multivariate analyses were performed using the Cox proportional hazard model to predict the factors related to the patients‘ overall survival rates. HMGB1 and VEGF-C expression were observed in 81 (48.80%) and 88 (53.01%) tumors, respectively, significantly higher than the rates among the corresponding controls. In addition, HMGB1 and VEGF-C expression were positively correlated (R2 = 0.972). HMGB1 expression was also closely associated with tumor size, pT stage, nodal status, metastasis status, TNM stage, and poor prognosis. Multivariate survival analysis indicated that patients with HMGB1 and VEGF-C coexpression had the worst prognoses and survival rates (hazard ratio, 2.78; log rank P<0.001). HMGB1 is commonly expressed in GC. Combined evaluation of HMGB1 and VEGF-C may serve as a valuable independent prognostic factor for GC patients.